Patient education companion set featuring handouts on DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, and medications used to treat type 2 diabetes (English and Spanish)

Patient education handout showing medications used to treat type 2 diabetes and where and how these medications work in the body to lower blood glucose.

Patient education handout showing medications used to treat type 2 diabetes and where and how these medications work in the body to lower blood glucose—in Spanish.

Pharmacologic treatment options for type 2 diabetes from the 2016 ADA guidelines

Diabetes management guidelines for nutrition from the American Diabetes Association (ADA)

Diabetes management guidelines from the American Association of Clinical Endocrinologists (AACE)

NDEI.org Expert commentary on the European Exenatide (EUREXA) Trial from Burton Sobel, MD.

NDEI.org expert commentary on European Exenatide (EUREXA) trial from Burton Sobel, MD

Joint position statement from ADA/EASD with clinical practice recommendations for managing hyperglycemia in type 2 diabetes

Vlckova V, Cornelius V, Kasliwal R, Wilton L, Shakir SA. Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide. ACC Abstracts of the 48th Scientific Session. 2009;32(5):409-418. Hypoglycaemia is an acute complication associated with intensive treatment of patients with diabetes mellitus. This complication poses a major challenge in diabetes management.